Navigation Links
Cancer gene mystery to be cracked!

A major research project is to be launched by researchers from the UK and Netherlands in the hope of identifying the cluster of genes associated with cancer. The research will be led by Dr. Julian Downward from Cancer Research UK’s London Research Institute, along with Dr. René Bernards of the Netherlands Cancer Institute. This research will build on the success of the human genome project and will have scientists looking at nearly 10,000 genes, inactivating one at a time to find out precisely what they do and how they contribute to the development of cancer. They hope// that this effort will ultimately lead to the creation of new drugs that target rogue cancer-causing genes.

Scientists will use a process called RNA interference to switch off certain genes and leave others unaffected. This process was first identified as taking place in the nematode worm. It was discovered that the worm used tiny pieces of double-stranded RNA to switch off rogue genes that would otherwise harm it. Subsequently, researchers found that synthetically produced RNA sequences could be used to target genes in human cells. Using this discovery, scientists will bombard cancer cells with 30,000 pieces of interference RNA in an effort to discover the genetic essence of a malignant cell. The researchers will then screen the treated cells for those that have reverted to type and become normal again. They hope that those genes switched off by RNA interference in these cells may represent a crucial group of genes, which future anti-cancer drugs could target.

Dr. Downward concluded that they were confident that they would precisely find out what needs to be taken away from cancerous cells to make it normal again. Sir Paul Nurse, Chief Executive of Cancer Research, UK, on the other hand, added that the next challenge for scientists was to unravel the mystery of each human gene and find out what each gene was doing. This would help in working out which of them are playing import ant roles in cancer and other diseases.

'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... 2016 , ... Compliancy Group LLC is pleased to offer ... the country. The Guard was specifically designed to handle each element required for ... updates, and compliance coaching. , In addition to meeting the compliance needs of ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize ... can leave patients with dental emergencies at risk of losing a tooth or their ... care. , Common dental emergencies include:, , Avulsed or ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... Indianapolis, IN (PRWEB) , ... February 10, 2016 ... ... employee benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its ... and has seven other locations throughout the Southeast, from Orlando to Huntsville and ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016 /PRNewswire/ ... a synergistic confluence of various technologies that ... propositions, previously unavailable. These opportunities create a ... convergence, in turn, drives the development of ... scenario is characterized by technology convergences, which ...
(Date:2/10/2016)... 2016 Mast Therapeutics, Inc. (NYSE ... for sickle cell disease and heart failure, today announced ... units at a price to the public of $0.275 ... the Company,s common stock and one warrant to purchase ... exercise price of $0.42 per share. The warrants are ...
Breaking Medicine Technology: